/Investor DB

TechAviv Founder Partners — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Cellular Intelligencecellularintelligence.comin𝕏Pre-Seed · Apr 2024 · $10M

Cellular Intelligence develops cell therapy treatments, specifically acquiring STEM-PD, a Phase 2-ready therapy for Parkinson's disease.

AI & Machine LearningBiotechMedical Devices

Micha Breakstone(CEO & co-founder)inAllon Klein(Scientific Co-founder)inOlivier Pourquié(Scientific Co-founder)inCliff Tabin(Scientific Co-founder)inJay Shendure(Scientific Co-founder)in

Co-investorsAstellas Venture Management LLCDarkmode VenturesFusionHarpoon VenturesLerer Hippeaumark vc+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.